Proleukin structure. Aldesleukin 18 million international units equals 1.

Proleukin structure. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form. Uses Side effects Warnings Before taking Dosage Interactions Sep 23, 2025 · As a biologic, PROLEUKIN’s manufacturing complexity influences supply stability and cost structure. Pharmacodynamics PROLEUKIN® (aldesleukin) an analogue of human interleukin-2 produced by recombinant DNA technology, has been shown to possess the biological activities of human native interleukin-2. Aldesleukin 18 million international units equals 1. com on Feb 17, 2025. This drug works by activating cells of the immune system (T lymphocytes) to attack and kill cancer cells. pdf>) are biologic agents used in the treatment of renal cell carcinoma and melanomas. 1 mg of protein. Proleukin® (aldesleukin) has been shown to possess the biological activities of human native interleukin-2. PROLEUKIN exhibits antitumour activity; the exact mechanism by which PROLEUKIN mediates its antitumor activity in animals and humans is unknown. yaqf2 5dgy kzonb u3l3f ab taes724 of8 xvw mu ryxs